SHA:600211 Market Cap

SHA:600211 has a market cap or net worth of 13.42 billion as of March 9, 2026. Its market cap has increased by 14.05% in one year.

Market Cap

13.42B

Enterprise Value

11.50B

Revenue

2.72B

Ranking

n/a

PE Ratio

13.69

Stock Price

41.63

Market Cap Chart

Since October 20, 1999, SHA:600211's market cap has increased from 1.45B to 13.42B, an increase of 826.64%. That is a compound annual growth rate of 8.80%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	13.42B	-2.16%
Dec 31, 2025	13.71B	15.19%
Dec 31, 2024	11.91B	-1.59%
Dec 29, 2023	12.10B	35.86%
Dec 30, 2022	8.91B	-31.40%
Dec 31, 2021	12.98B	-22.18%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Beijing Aosaikang Pharmaceutical	13.58B
Shenzhen Chipscreen Biosciences	13.49B
Shanghai Haoyuan Chemexpress	13.30B
ApicHope Pharmaceutical Group	14.33B
Shanghai Shyndec Pharmaceutical	14.52B
Zhejiang Jingxin Pharmaceutical	12.80B
Guobang Pharma	14.74B
Zhejiang Jiuzhou Pharmaceutical	14.83B

Market Cap Rankings